Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
We here evaluate the humoral and cellular immune response against SARS-CoV-2 in 41 COVID-19 convalescents. As previous studies mostly included younger individuals, one advantage of our study is the comparatively high mean age of the convalescents included in the cohort considered (54 ± 8.4 years). W...
Main Authors: | Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/8/805 |
Similar Items
-
The Human Myofibroblast Marker Xylosyltransferase-I: A New Indicator for Macrophage Polarization
by: Thanh-Diep Ly, et al.
Published: (2022-11-01) -
Linking ABCC6 Deficiency in Primary Human Dermal Fibroblasts of PXE Patients to p21-Mediated Premature Cellular Senescence and the Development of a Proinflammatory Secretory Phenotype
by: Janina Tiemann, et al.
Published: (2020-12-01) -
Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease progression
by: Ingvild Birschmann, et al.
Published: (2022-09-01) -
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study
by: Jonas Herzberg, et al.
Published: (2022-07-01) -
Immunomodulatory effects of pneumococcal extracellular vesicles on cellular and humoral host defenses
by: Codemo, Mario, et al.
Published: (2019)